Affiliation:
1. New
Product Research Laboratories I, Daiichi Pharmaceutical Co. Ltd.,
Tokyo, Japan
Abstract
ABSTRACT
The
in vitro activities of DX-619, des-fluoro(6) quinolone, against 1,208
clinical isolates were examined. DX-619 was particularly potent against
staphylococci, including ciprofloxacin- and methicillin-resistant
strains; the MIC at which 90% of the strains tested were inhibited was
0.5 μg/ml. In addition, DX-619 was also active against
gram-negative
bacteria.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献